Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

A Double-Blind, Randomized Trial Shows the Role of Zonal Priming and Direct Topical Application of Epigallocatechin-3-Gallate in the Modulation of Cutaneous Scarring in Human Skin.

Ud-Din S, Foden P, Mazhari M, Al-Habba S, Baguneid M, Bulfone-Paus S, McGeorge D, Bayat A.

J Invest Dermatol. 2019 Aug;139(8):1680-1690.e16. doi: 10.1016/j.jid.2019.01.030. Epub 2019 Feb 26.

PMID:
30822414
2.

Mast cell disorders: From infancy to maturity.

Wilcock A, Bahri R, Bulfone-Paus S, Arkwright PD.

Allergy. 2019 Jan;74(1):53-63. doi: 10.1111/all.13657. Epub 2018 Nov 28. Review.

PMID:
30390314
3.

Aged human skin accumulates mast cells with altered functionality that localize to macrophages and vasoactive intestinal peptide-positive nerve fibres.

Pilkington SM, Barron MJ, Watson REB, Griffiths CEM, Bulfone-Paus S.

Br J Dermatol. 2019 Apr;180(4):849-858. doi: 10.1111/bjd.17268. Epub 2018 Dec 6.

4.

Reply.

Bulfone-Paus S, Bahri R, Shamji MH, Custovic A, Turner PJ.

J Allergy Clin Immunol. 2018 Sep;142(3):1019. doi: 10.1016/j.jaci.2018.06.021. Epub 2018 Jul 25. No abstract available.

PMID:
30055830
5.

Nuclear factor (erythroid-derived 2)-like-2 pathway modulates substance P-induced human mast cell activation and degranulation in the hair follicle.

Jadkauskaite L, Bahri R, Farjo N, Farjo B, Jenkins G, Bhogal R, Haslam I, Bulfone-Paus S, Paus R.

J Allergy Clin Immunol. 2018 Oct;142(4):1331-1333.e8. doi: 10.1016/j.jaci.2018.04.039. Epub 2018 May 31. No abstract available.

PMID:
29859202
6.

Mast cell activation test in the diagnosis of allergic disease and anaphylaxis.

Bahri R, Custovic A, Korosec P, Tsoumani M, Barron M, Wu J, Sayers R, Weimann A, Ruiz-Garcia M, Patel N, Robb A, Shamji MH, Fontanella S, Silar M, Mills ENC, Simpson A, Turner PJ, Bulfone-Paus S.

J Allergy Clin Immunol. 2018 Aug;142(2):485-496.e16. doi: 10.1016/j.jaci.2018.01.043. Epub 2018 Mar 5.

7.

Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management.

Paus R, Bulfone-Paus S, Bertolini M.

J Investig Dermatol Symp Proc. 2018 Jan;19(1):S12-S17. doi: 10.1016/j.jisp.2017.10.014. Review.

8.

The Role of Mast Cells in Tuberculosis: Orchestrating Innate Immune Crosstalk?

Garcia-Rodriguez KM, Goenka A, Alonso-Rasgado MT, Hernández-Pando R, Bulfone-Paus S.

Front Immunol. 2017 Oct 17;8:1290. doi: 10.3389/fimmu.2017.01290. eCollection 2017. Review.

9.

Positive and Negative Signals in Mast Cell Activation.

Bulfone-Paus S, Nilsson G, Draber P, Blank U, Levi-Schaffer F.

Trends Immunol. 2017 Sep;38(9):657-667. doi: 10.1016/j.it.2017.01.008. Epub 2017 Feb 20. Review.

PMID:
28254170
10.

High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner.

Polansky JK, Bahri R, Divivier M, Duitman EH, Vock C, Goyeneche-Patino DA, Orinska Z, Bulfone-Paus S.

Sci Rep. 2016 Jan 29;6:19699. doi: 10.1038/srep19699.

11.

CD252 regulates mast cell mediated, CD1d-restricted NKT-cell activation in mice.

Gonzalez Roldan N, Orinska Z, Ewers H, Bulfone-Paus S.

Eur J Immunol. 2016 Feb;46(2):432-9. doi: 10.1002/eji.201545879. Epub 2015 Dec 9.

12.

IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity.

Bahri R, Pateras IS, D'Orlando O, Goyeneche-Patino DA, Campbell M, Polansky JK, Sandig H, Papaioannou M, Evangelou K, Foukas PG, Gorgoulis VG, Bulfone-Paus S.

Oncoimmunology. 2015 Jan 22;4(9):e1002721. eCollection 2015 Sep.

13.

Mast Cells as Regulators of T Cell Responses.

Bulfone-Paus S, Bahri R.

Front Immunol. 2015 Aug 7;6:394. doi: 10.3389/fimmu.2015.00394. eCollection 2015. Review.

14.

miRNA-155 controls mast cell activation by regulating the PI3Kγ pathway and anaphylaxis in a mouse model.

Biethahn K, Orinska Z, Vigorito E, Goyeneche-Patino DA, Mirghomizadeh F, Föger N, Bulfone-Paus S.

Allergy. 2014 Jun;69(6):752-62. doi: 10.1111/all.12407. Epub 2014 Apr 15.

PMID:
24734904
15.

Listeria monocytogenes alters mast cell phenotype, mediator and osteopontin secretion in a listeriolysin-dependent manner.

Jobbings CE, Sandig H, Whittingham-Dowd JK, Roberts IS, Bulfone-Paus S.

PLoS One. 2013;8(2):e57102. doi: 10.1371/journal.pone.0057102. Epub 2013 Feb 27.

16.

IL-33 causes selective mast cell tolerance to bacterial cell wall products by inducing IRAK1 degradation.

Sandig H, Jobbings CE, Roldan NG, Whittingham-Dowd JK, Orinska Z, Takeuchi O, Akira S, Bulfone-Paus S.

Eur J Immunol. 2013 Apr;43(4):979-88. doi: 10.1002/eji.201242786. Epub 2013 Mar 6.

17.

Syntaxin 11 is required for NK and CD8⁺ T-cell cytotoxicity and neutrophil degranulation.

D'Orlando O, Zhao F, Kasper B, Orinska Z, Müller J, Hermans-Borgmeyer I, Griffiths GM, Zur Stadt U, Bulfone-Paus S.

Eur J Immunol. 2013 Jan;43(1):194-208. doi: 10.1002/eji.201142343. Epub 2012 Dec 12.

18.

Ectonucleotidase CD38 demarcates regulatory, memory-like CD8+ T cells with IFN-γ-mediated suppressor activities.

Bahri R, Bollinger A, Bollinger T, Orinska Z, Bulfone-Paus S.

PLoS One. 2012;7(9):e45234. doi: 10.1371/journal.pone.0045234. Epub 2012 Sep 17.

19.

TLR signaling in mast cells: common and unique features.

Sandig H, Bulfone-Paus S.

Front Immunol. 2012 Jul 4;3:185. doi: 10.3389/fimmu.2012.00185. eCollection 2012.

20.

IL-15 inhibits IL-7Rα expression by memory-phenotype CD8⁺ T cells in the bone marrow.

Quinci AC, Vitale S, Parretta E, Soriani A, Iannitto ML, Cippitelli M, Fionda C, Bulfone-Paus S, Santoni A, Di Rosa F.

Eur J Immunol. 2012 May;42(5):1129-39. doi: 10.1002/eji.201142019.

21.

Interleukin 15 mediates joint destruction in Staphylococcus aureus arthritis.

Henningsson L, Jirholt P, Bogestål YR, Eneljung T, Adiels M, Lindholm C, McInnes I, Bulfone-Paus S, Lerner UH, Gjertsson I.

J Infect Dis. 2012 Sep 1;206(5):687-96. doi: 10.1093/infdis/jis295. Epub 2012 Apr 16.

PMID:
22508940
22.

Differential regulation of mast cell degranulation versus cytokine secretion by the actin regulatory proteins Coronin1a and Coronin1b.

Föger N, Jenckel A, Orinska Z, Lee KH, Chan AC, Bulfone-Paus S.

J Exp Med. 2011 Aug 29;208(9):1777-87. doi: 10.1084/jem.20101757. Epub 2011 Aug 15.

23.

Mechanisms of cytokine secretion: a portfolio of distinct pathways allows flexibility in cytokine activity.

Duitman EH, Orinska Z, Bulfone-Paus S.

Eur J Cell Biol. 2011 Jun-Jul;90(6-7):476-83. doi: 10.1016/j.ejcb.2011.01.010. Epub 2011 Mar 24. Review.

PMID:
21439673
24.

Retraction: Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells.

Orinska Z, Hein M, Petersen F, Bulfone-Paus S, Thon L, Adam D.

J Immunol. 2011 Feb 15;186(4):2683. doi: 10.4049/jimmunol.1090144. No abstract available.

25.

Retraction: Mast cells express novel functional IL-15 receptor α isoforms.

Krause H, Paus R, Orinska Z, Bulfone-Paus S.

J Immunol. 2011 Feb 15;186(4):2682. doi: 10.4049/jimmunol.1090143. No abstract available.

26.

Retraction: The IL-15Rα chain signals through association with Syk in human B cells.

Pohl T, Krause H, Dürkop H, Paus R, Bulfone-Paus S.

J Immunol. 2011 Feb 15;186(4):2681. doi: 10.4049/jimmunol.1090142. No abstract available.

27.

I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development.

Orinska Z, Föger N, Huber M, Marschall J, Mirghomizadeh F, Du X, Scheller M, Rosenstiel P, Goldmann T, Bollinger A, Beutler BA, Bulfone-Paus S.

Blood. 2010 Oct 14;116(15):2665-75. doi: 10.1182/blood-2009-06-228460. Epub 2010 Jul 1. Erratum in: Blood. 2011 Jun 30;117(26):7186.

PMID:
20595514
28.

Injury to the stratum corneum induces in vivo expression of human thymic stromal lymphopoietin in the epidermis.

Angelova-Fischer I, Fernandez IM, Donnadieu MH, Bulfone-Paus S, Zillikens D, Fischer TW, Soumelis V.

J Invest Dermatol. 2010 Oct;130(10):2505-7. doi: 10.1038/jid.2010.143. Epub 2010 Jun 17. No abstract available.

29.

P2 receptor-mediated signaling in mast cell biology.

Bulanova E, Bulfone-Paus S.

Purinergic Signal. 2010 Mar;6(1):3-17. doi: 10.1007/s11302-009-9173-z. Epub 2009 Nov 17.

30.

Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy.

Koch M, Savvatis K, Scheeler M, Dhayat S, Bonaventura K, Pohl T, Riad A, Bulfone-Paus S, Schultheiss HP, Tschöpe C.

Int Immunopharmacol. 2010 Feb;10(2):207-12. doi: 10.1016/j.intimp.2009.11.001. Epub 2009 Nov 6.

PMID:
19897056
31.

Common gamma-chain-dependent signals confer selective survival of eosinophils in the murine small intestine.

Carlens J, Wahl B, Ballmaier M, Bulfone-Paus S, Förster R, Pabst O.

J Immunol. 2009 Nov 1;183(9):5600-7. doi: 10.4049/jimmunol.0801581.

32.

Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions.

Stelekati E, Bahri R, D'Orlando O, Orinska Z, Mittrücker HW, Langenhaun R, Glatzel M, Bollinger A, Paus R, Bulfone-Paus S.

Immunity. 2009 Oct 16;31(4):665-76. doi: 10.1016/j.immuni.2009.08.022. Epub 2009 Oct 8.

33.

Transcriptional regulation of mouse mast cell protease-2 by interleukin-15.

Mirghomizadeh F, Bullwinkel J, Orinska Z, Janssen O, Petersen A, Singh PB, Bulfone-Paus S.

J Biol Chem. 2009 Nov 20;284(47):32635-41. doi: 10.1074/jbc.M109.015446. Epub 2009 Oct 1.

34.

Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway.

Scutera S, Fraone T, Musso T, Cappello P, Rossi S, Pierobon D, Orinska Z, Paus R, Bulfone-Paus S, Giovarelli M.

J Immunol. 2009 Sep 1;183(5):3004-13. doi: 10.4049/jimmunol.0804384. Epub 2009 Aug 5.

35.

Intracellular IL-15 controls mast cell survival.

Mirghomizadeh F, Winoto-Morbach S, Orinska Z, Lee KH, Schütze S, Bulfone-Paus S.

Exp Cell Res. 2009 Oct 15;315(17):3064-75. doi: 10.1016/j.yexcr.2009.07.019. Epub 2009 Jul 23.

PMID:
19632221
36.

Subcellular compartmentalization of FADD as a new level of regulation in death receptor signaling.

Föger N, Bulfone-Paus S, Chan AC, Lee KH.

FEBS J. 2009 Aug;276(15):4256-65. doi: 10.1111/j.1742-4658.2009.07134.x. Epub 2009 Jul 3.

37.

Anti-CD30 human IL-2 fusion proteins display strong and specific cytotoxicity in vivo.

Hirsch B, Brauer J, Fischdick M, Loddenkemper C, Bulfone-Paus S, Stein H, Dürkop H.

Curr Drug Targets. 2009 Feb;10(2):110-7. Review.

PMID:
19199906
38.

ATP induces P2X7 receptor-independent cytokine and chemokine expression through P2X1 and P2X3 receptors in murine mast cells.

Bulanova E, Budagian V, Orinska Z, Koch-Nolte F, Haag F, Bulfone-Paus S.

J Leukoc Biol. 2009 Apr;85(4):692-702. doi: 10.1189/jlb.0808470. Epub 2009 Jan 21. Retraction in: J Leukoc Biol. 2011 Mar;89(3):489.

PMID:
19164130
39.

Interleukin-15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis?

Rückert R, Brandt K, Ernst M, Marienfeld K, Csernok E, Metzler C, Budagian V, Bulanova E, Paus R, Bulfone-Paus S.

Immunology. 2009 Jan;126(1):63-73. doi: 10.1111/j.1365-2567.2008.02878.x. Epub 2008 Jun 13.

40.

Trans-presentation of IL-15 dictates IFN-producing killer dendritic cells effector functions.

Ullrich E, Bonmort M, Mignot G, Jacobs B, Bosisio D, Sozzani S, Jalil A, Louache F, Bulanova E, Geissman F, Ryffel B, Chaput N, Bulfone-Paus S, Zitvogel L.

J Immunol. 2008 Jun 15;180(12):7887-97.

41.

How a cytokine is chaperoned through the secretory pathway by complexing with its own receptor: lessons from interleukin-15 (IL-15)/IL-15 receptor alpha.

Duitman EH, Orinska Z, Bulanova E, Paus R, Bulfone-Paus S.

Mol Cell Biol. 2008 Aug;28(15):4851-61. doi: 10.1128/MCB.02178-07. Epub 2008 May 27. Erratum in: Mol Cell Biol. 2010 May;30(10):2578.

42.

IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Brandenburg S, Takahashi T, de la Rosa M, Janke M, Karsten G, Muzzulini T, Orinska Z, Bulfone-Paus S, Scheffold A.

Eur J Immunol. 2008 Jun;38(6):1643-53. doi: 10.1002/eji.200737791.

43.

The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2.

Mignot G, Ullrich E, Bonmort M, Ménard C, Apetoh L, Taieb J, Bosisio D, Sozzani S, Ferrantini M, Schmitz J, Mack M, Ryffel B, Bulfone-Paus S, Zitvogel L, Chaput N.

J Immunol. 2008 May 15;180(10):6477-83.

44.

Osteopontin as a new player in mast cell biology.

Bulfone-Paus S, Paus R.

Eur J Immunol. 2008 Feb;38(2):338-41. doi: 10.1002/eji.200738131. Review.

45.

Interleukin-21 stimulates antigen uptake, protease activity, survival and induction of CD4+ T cell proliferation by murine macrophages.

Rückert R, Bulfone-Paus S, Brandt K.

Clin Exp Immunol. 2008 Mar;151(3):487-95. doi: 10.1111/j.1365-2249.2007.03581.x. Epub 2008 Jan 8.

46.

CCR7 signaling inhibits T cell proliferation.

Ziegler E, Oberbarnscheidt M, Bulfone-Paus S, Förster R, Kunzendorf U, Krautwald S.

J Immunol. 2007 Nov 15;179(10):6485-93.

47.

IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities.

Orinska Z, Maurer M, Mirghomizadeh F, Bulanova E, Metz M, Nashkevich N, Schiemann F, Schulmistrat J, Budagian V, Giron-Michel J, Brandt E, Paus R, Bulfone-Paus S.

Nat Med. 2007 Aug;13(8):927-34. Epub 2007 Jul 22.

PMID:
17643110
48.

Mast cells in allergy: innate instructors of adaptive responses.

Stelekati E, Orinska Z, Bulfone-Paus S.

Immunobiology. 2007;212(6):505-19. Epub 2007 May 7. Review.

PMID:
17544835
49.

Interleukin-21: a new modulator of immunity, infection, and cancer.

Brandt K, Singh PB, Bulfone-Paus S, Rückert R.

Cytokine Growth Factor Rev. 2007 Jun-Aug;18(3-4):223-32. Epub 2007 May 16. Review.

PMID:
17509926
50.

Soluble Interleukin IL-15Ralpha is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15.

Bulanova E, Budagian V, Duitman E, Orinska Z, Krause H, Rückert R, Reiling N, Bulfone-Paus S.

J Biol Chem. 2007 May 4;282(18):13167-79. Epub 2007 Feb 27. Retraction in: J Biol Chem. 2011 Feb 18;286(7):5934.

Supplemental Content

Loading ...
Support Center